EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ITPR3 ‐associated neuropathy: Report of a further family with adult onset intermediate Charcot–Marie–Tooth disease

Javier Cabello-Murgui iD, Jesús Jiménez-Jiménez iD, Juan J Vílchez iD, Inmaculada Azorín iD, Pilar Martí-Martínez iD, Elvira Millet, Vincenzo Lupo iD, Teresa Sevilla iD, Rafael Sivera iD

European Journal of Neurology · 2024

DOI: 10.1111/ene.16485 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Javier Cabello-Murgui und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neuromuscular Diseases Unit, Department of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain. Hauptthemen laut MEDLINE: Charcot-Marie-Tooth Disease, Inositol 1,4,5-Trisphosphate Receptors, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose ITPR3 encodes type 3 inositol‐tri‐phosphate receptor (IP 3 R3), a protein expressed in Schwann cells, predominantly in the paranodal region, and involved in the regulation of Ca 2+ release from the endoplasmic reticulum. Dominant variants in ITPR3 have recently been recognized as a rare cause of intermediate Charcot–Marie–Tooth disease (CMT).

Methods

We collected the clinical data of a family with autosomal dominant neuropathy whose proband was diagnosed with chronic inflammatory demyelinating polyneuropathy (CIDP) for many years. The genetic diagnosis was achieved by whole exome sequencing.

Results

The proband developed symmetrical sensory–motor neuropathy with demyelinating features at 32 years old. He was diagnosed with CIDP and received numerous immunomodulatory treatments. However, his condition progressed, leading to severe proximal leg and hand atrophy that confined him to a wheelchair at 60 years. The patient's two sons began to exhibit symptoms suggestive of neuropathy shortly after age 30 years, and the condition was reoriented as inherited. Exome sequencing identified a heterozygous c.4271C > T variant in the ITPR3 gene segregating with the disease. Nerve conduction studies showed a combination of demyelinating and axonal features that vary by nerve, disease duration, and patient. A uniform thickening of the nerves was identified on nerve echography, as was distal symmetric fatty infiltration in lower limb muscle imaging.

Conclusions

The c.4271C > T ITPR3 variant causes a late onset CMT that can be considered an intermediate CMT. Considering the electrophysiological findings and the distribution of IP 3 R3, we hypothesize that this variant could start as nodal dysfunction that progresses to widespread nerve degeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Charcot-Marie-Tooth DiseaseInositol 1,4,5-Trisphosphate ReceptorsPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingAdultHumansMaleMiddle AgedAge of OnsetExome SequencingMutationPedigree

Stichwörter der Autor:innen

ITPR3intermediate CMTlate onset CMTnode of Ranviernodo‐paranodopathy

Substanzen

Inositol 1,4,5-Trisphosphate ReceptorsITPR3 protein, human

Autor:innen und Institutionen

  • Neuromuscular Diseases Unit, Department of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
  • Neuromuscular and Ataxias Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III (U763), Madrid, Spain.
  • Rare Neurodegenerative Diseases Laboratory, Centro de Investigación Príncipe Felipe, Valencia, Spain.
  • Department of Medicine, Universitat de València, Valencia, Spain.

ORCID-Profile: Javier Cabello-Murgui, Jesús Jiménez-Jiménez, Juan J Vílchez, Inmaculada Azorín, Pilar Martí-Martínez, Vincenzo Lupo, Teresa Sevilla, Rafael Sivera

Förderung

  • Instituto de Salud Carlos III
  • European Regional Development Fund

Zitieren

APA

Cabello-Murgui, J., Jiménez-Jiménez, J., Vílchez, J. J., Azorín, I., Martí-Martínez, P., Millet, E., Lupo, V., Sevilla, T., & Sivera, R. (2024). ITPR3 ‐associated neuropathy: Report of a further family with adult onset intermediate Charcot–Marie–Tooth disease. European Journal of Neurology. https://doi.org/10.1111/ene.16485

Vancouver

Cabello-Murgui J, Jiménez-Jiménez J, Vílchez JJ, Azorín I, Martí-Martínez P, Millet E, et al. ITPR3 ‐associated neuropathy: Report of a further family with adult onset intermediate Charcot–Marie–Tooth disease. European Journal of Neurology. 2024. doi:10.1111/ene.16485

BibTeX
@article{CabelloMurgui2024,
  author = {Cabello-Murgui, Javier and Jiménez-Jiménez, Jesús and Vílchez, Juan J and Azorín, Inmaculada and Martí-Martínez, Pilar and Millet, Elvira and Lupo, Vincenzo and Sevilla, Teresa and Sivera, Rafael},
  title = {ITPR3 ‐associated neuropathy: Report of a further family with adult onset intermediate Charcot–Marie–Tooth disease},
  journal = {European Journal of Neurology},
  year = {2024},
  doi = {10.1111/ene.16485}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche